These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20921236)

  • 1. Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.
    Reston JT; Uhl S; Treadwell JR; Nash RA; Schoelles K
    Mult Scler; 2011 Feb; 17(2):204-13. PubMed ID: 20921236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
    Mancardi GL; Sormani MP; Di Gioia M; Vuolo L; Gualandi F; Amato MP; Capello E; Currò D; Uccelli A; Bertolotto A; Gasperini C; Lugaresi A; Merelli E; Meucci G; Motti L; Tola MR; Scarpini E; Repice AM; Massacesi L; Saccardi R;
    Mult Scler; 2012 Jun; 18(6):835-42. PubMed ID: 22127896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of bone marrow transplantation treatment studies: mixing 'apples and oranges'.
    Freedman MS; Cohen JA
    Mult Scler; 2011 Feb; 17(2):131-2. PubMed ID: 21296831
    [No Abstract]   [Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
    Saccardi R; Kozak T; Bocelli-Tyndall C; Fassas A; Kazis A; Havrdova E; Carreras E; Saiz A; Löwenberg B; te Boekhorst PA; Gualandio F; Openshaw H; Longo G; Pagliai F; Massacesi L; Deconink E; Ouyang J; Nagore FJ; Besalduch J; Lisukov IA; Bonini A; Merelli E; Slavino S; Gratwohl A; Passweg J; Tyndall A; Steck AJ; Andolina M; Capobianco M; Martin JL; Lugaresi A; Meucci G; Sáez RA; Clark RE; Fernandez MN; Fouillard L; Herstenstein B; Koza V; Cocco E; Baurmann H; Mancardi GL;
    Mult Scler; 2006 Dec; 12(6):814-23. PubMed ID: 17263012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kurbatova KA; Gorodokin GI; Novik AA
    Ann Hematol; 2015 Jul; 94(7):1149-57. PubMed ID: 25711670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.
    Xu J; Ji BX; Su L; Dong HQ; Sun WL; Wan SG; Liu YO; Zhang P; Liu CY
    Ann Hematol; 2011 Mar; 90(3):343-8. PubMed ID: 20872003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D; Tukić L; Radovinović-Tasić S; Petrović B; Elez M; Ostojić G; Balint B
    Vojnosanit Pregl; 2016 May; 73(5):504-8. PubMed ID: 27430119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
    Burman J; Iacobaeus E; Svenningsson A; Lycke J; Gunnarsson M; Nilsson P; Vrethem M; Fredrikson S; Martin C; Sandstedt A; Uggla B; Lenhoff S; Johansson JE; Isaksson C; Hägglund H; Carlson K; Fagius J
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1116-21. PubMed ID: 24554104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study.
    Curro' D; Vuolo L; Gualandi F; Bacigalupo A; Roccatagliata L; Capello E; Uccelli A; Saccardi R; Sormani MP; Mancardi G
    Mult Scler; 2015 Oct; 21(11):1423-30. PubMed ID: 25583838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
    Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
    JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis.
    Shevchenko JL; Kuznetsov AN; Ionova TI; Melnichenko VY; Fedorenko DA; Kartashov AV; Kurbatova KA; Gorodokin GI; Novik AA
    Exp Hematol; 2012 Nov; 40(11):892-8. PubMed ID: 22771495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of autologous hematopoietic stem-cell transplantation in multiple sclerosis: a systematic review and meta-analysis.
    Ge F; Lin H; Li Z; Chang T
    Neurol Sci; 2019 Mar; 40(3):479-487. PubMed ID: 30535563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up more than 10 years after HSCT: a monocentric experience.
    Frau J; Carai M; Coghe G; Fenu G; Lorefice L; La Nasa G; Mamusa E; Vacca A; Marrosu MG; Cocco E
    J Neurol; 2018 Feb; 265(2):410-416. PubMed ID: 29270686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
    Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
    J Clin Oncol; 2011 Aug; 29(22):3016-22. PubMed ID: 21730266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B; Jarque I; Gascón F; Hernández-Boluda JC; Pérez-Miralles F; de la Rubia J; Alcalá C; Sanz J; Mallada J; Cervelló A; Navarré A; Carcelén-Gadea M; Boscá I; Gil-Perotin S; Solano C; Sanz MA; Coret F
    Neurol Sci; 2017 Jul; 38(7):1213-1221. PubMed ID: 28396953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab-containing reduced intensity conditioning allogenic hematopoietic stem cell transplantation in a case of primary progressive multiple sclerosis.
    AlKhaja M; Abanmy A; AlKhdairi A; AlRasheedi S; AlZahrani H; AlKhawajah M
    Mult Scler Relat Disord; 2018 Oct; 25():334-336. PubMed ID: 30195202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
    Burt RK; Loh Y; Cohen B; Stefoski D; Balabanov R; Katsamakis G; Oyama Y; Russell EJ; Stern J; Muraro P; Rose J; Testori A; Bucha J; Jovanovic B; Milanetti F; Storek J; Voltarelli JC; Burns WH
    Lancet Neurol; 2009 Mar; 8(3):244-53. PubMed ID: 19186105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.
    Mancardi GL; Sormani MP; Gualandi F; Saiz A; Carreras E; Merelli E; Donelli A; Lugaresi A; Di Bartolomeo P; Rottoli MR; Rambaldi A; Amato MP; Massacesi L; Di Gioia M; Vuolo L; Currò D; Roccatagliata L; Filippi M; Aguglia U; Iacopino P; Farge D; Saccardi R; ;
    Neurology; 2015 Mar; 84(10):981-8. PubMed ID: 25672923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.
    Xu J; Ji BX; Su L; Dong HQ; Sun XJ; Liu CY
    Chin Med J (Engl); 2006 Nov; 119(22):1851-5. PubMed ID: 17134581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.